Design of oligonucleotides as RNA-based drugs: prerequisites and opportunities for in silico methods within the framework of fragment-based approaches

Fabrice Leclerc

Communication Dans Un Congrès Année : 2020

Design of oligonucleotides as RNA-based drugs: prerequisites and opportunities for in silico methods within the framework of fragment-based approaches

(1)

1

Fabrice Leclerc

Fonction : Auteur
PersonId : 5492
IdHAL : fabrice-leclerc
ORCID : 0000-0002-5641-1525
IdRef : 231160992

Institut de Biologie Intégrative de la Cellule

CV

Domaines

Bio-informatique [q-bio.QM] Chimie théorique et/ou physique Biologie structurale [q-bio.BM] Biophysique Chimie thérapeutique

jobim2020_minisympRNA_FL.pdf (16.34 Mo)

Origine : Fichiers produits par l'(les) auteur(s)

Fabrice Leclerc : Connectez-vous pour contacter le contributeur

https://hal.science/hal-03313254

Soumis le : mardi 3 août 2021-16:24:36

Dernière modification le : lundi 22 avril 2024-13:18:03

Dates et versions

hal-03313254 , version 1 (03-08-2021)

Identifiants

HAL Id : hal-03313254 , version 1

Citer

Fabrice Leclerc. Design of oligonucleotides as RNA-based drugs: prerequisites and opportunities for in silico methods within the framework of fragment-based approaches. Mini-symposium@JOBIM 2020 - RNA structure, design and interactions with proteins, Jul 2020, Montpellier (en ligne), France. ⟨hal-03313254⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CEA CNRS CEA-UPSAY I2BC UNIV-PARIS-SACLAY JOLIOT CEA-DRF GS-ENGINEERING GS-BIOSPHERA GS-LIFE-SCIENCES-HEALTH GS-HEALTH-DRUG-SCIENCES INSTITUT-SCIENCES-LUMIERE

35 Consultations

8 Téléchargements

Design of oligonucleotides as RNA-based drugs: prerequisites and opportunities for in silico methods within the framework of fragment-based approaches

Domaines

Dates et versions

Identifiants

Citer

Exporter

Collections

Partager